What are the differences between the adult and paediatric formulations of Movicol (macrogol 3350)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Movicol Adult vs Paediatric Formulations

The primary difference between Movicol adult and paediatric formulations is the concentration and sachet size: Movicol Paediatric Plain contains 6.9g of macrogol 3350 per sachet (half the adult dose), is unflavored to improve palatability in children, and is specifically designed for easier dose titration in children aged 2-11 years, while the adult formulation contains 13.8g per sachet.

Key Formulation Differences

Dose Concentration

  • Adult Movicol: 13.8g macrogol 3350 per sachet
  • Paediatric Movicol Plain: 6.9g macrogol 3350 per sachet (50% of adult dose) 1

This lower concentration allows for more precise weight-based dosing in children, as pediatric dosing typically requires 1-2 sachets daily for maintenance therapy 2.

Flavoring

  • Paediatric formulation is unflavored ("Plain"), which paradoxically improves acceptance in children who often reject artificially flavored medications
  • Adult formulation may contain flavoring agents

Licensed Age Ranges

  • Paediatric: Licensed for chronic constipation in children 2-11 years; faecal impaction from 5 years 3
  • Adult: Licensed for use in patients ≥12 years

Clinical Dosing Implications

For Chronic Constipation

The paediatric formulation enables flexible dosing:

  • Children typically start with 1 sachet (6.9g) daily
  • Can be titrated up to 4 sachets daily based on response 2, 4
  • The smaller sachet size prevents overdosing in younger/smaller children

For Faecal Impaction

The paediatric formulation allows for escalating disimpaction protocols without the risk of excessive electrolyte administration that could occur with adult-strength sachets in small children 1, 5.

Safety Considerations

Critical caveat: While both formulations contain electrolytes (sodium, potassium, chloride, bicarbonate), the paediatric formulation's lower concentration per sachet reduces the risk of electrolyte disturbances in children, particularly those under 2 years (though use in this age group is off-label) 3. The electrolyte content is proportionally maintained to ensure iso-osmotic properties in both formulations 6.

Common Pitfall to Avoid

Do not simply halve adult sachets for children - the paediatric formulation exists specifically to provide accurate dosing and appropriate electrolyte balance. Using adult sachets in children risks dosing errors and makes titration more difficult.

Efficacy Evidence

Both formulations demonstrate excellent efficacy when used appropriately:

  • Paediatric studies show 87-92% achieve adequate bowel preparation 2
  • Mean defecation frequency increases from 1.4 to 7.1 per week in children 2
  • Long-term use (≥6 months) is safe and effective in children without dose adjustment needed for weight gain 4

The paediatric formulation has proven cost-effective, reducing hospital admissions by 92% compared to enemas/manual evacuation for faecal impaction 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.